Question 1

What is PHAXIAM Therapeutics S.A. (PHXM) stock price today?

Accepted Answer

PHAXIAM Therapeutics S.A. (PHXM) currently trades at $3.10 per share. The stock has a market capitalization of $28.90M and a P/E ratio of —x.

Question 2

Is PHXM stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, PHAXIAM Therapeutics S.A. has a Smart Value Score of 11/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is PHAXIAM Therapeutics S.A.'s revenue and earnings?

Accepted Answer

PHAXIAM Therapeutics S.A. has trailing twelve-month (TTM) revenue of $5.97M with profit margins of -191.00%. Earnings per share (EPS) is $-39.05.

Question 4

Is PHXM stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, PHAXIAM Therapeutics S.A.'s intrinsic value is $4.22, representing a margin of safety of 26.54%. The stock currently trades at a P/E of —x.

Metric	2020	2021	2022	2023	TTM
Revenue	$0.00	$0.00	$0.00	—	$5.97M
Net income	$-73.30M	$-53.80M	$-227000.00	$-23.49M	$-11.29M
EPS	—	—	—	—	$-39.05
Free cash flow	$-52.86M	$-57.07M	$-31.85M	$-24.58M	$-12.71M
Profit margin	—	—	—	—	-191.00%

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PHXM	$28.90M	11	3.7	2.0	6.0	5.0	+26.54%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-41.61%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-26.29%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.35%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

PHAXIAM Therapeutics S.A.

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare